AVANIR Pharmaceuticals Submits Complete Response To FDA Approvable Letter For Zenvia In PBA
Links shared publicly online about this topic.
- 1,192total visits
AVANIR Pharmaceuticals Submits Complete Response To FDA Approvable Letter For Zenvia In PBA
View full resource at medicalnewstoday.com
Most Recently Shared on May 5, 2010 at 3:07 am By:
AVANIR Pharmaceuticals Submits Complete Response To FDA Approvable Letter For Zenvia In PBA http://mnt.to/3C7P #regulatory
AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia
news-medical.net — “AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia" (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.” View full resource at news-medical.net
Most Recently Shared on May 3, 2010 at 8:38 am By:
AVANIR Pharmaceuticals announces filing of Complete Response to FDA Approvable Letter for Zenvia: AVANIR Pharmaceu... http://bit.ly/d0fdDE
Advertisement
